---
schema_version: "secwatch.filing_event.v1"
accession: "0001779128-24-000123"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2024-11-12T23:59:59+00:00"
generated_at: "2026-05-30T02:05:15.709245+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Blade Air Mobility Q3 revenue $74.9M (+4.8%); net loss $(2.0)M; Adj EBITDA $4.2M

## Summary
- Revenue $74.9M, up 4.8% YoY; gross margin improved 520 bps to 19.3%.
- Net loss $(2.0)M vs income $0.3M YoY; Adjusted EBITDA $4.2M, improvement of $3.4M.
- Operating cash flow $6.4M, up $4.3M; free cash flow before aircraft acquisitions $3.7M, up $2.4M.
- Medical segment Adj EBITDA improved 15.1%; Passenger segment Adj EBITDA up $2.8M, achieving trailing 12-month profitability.
- Reaffirmed guidance: positive Adjusted EBITDA in 2024 and double-digit millions in 2025; announced strategic alliance with OrganOx.

## SEC filing metadata
- accession: 0001779128-24-000123
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2024-11-12T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000177912824000123/0001779128-24-000123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000177912824000123/blde-20241112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001779128-24-000123
- JSON: https://secwatch.observer/filing/0001779128-24-000123.json
- Plain text: https://secwatch.observer/filing/0001779128-24-000123.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.